AJR Women's Imaging Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nesbit, G.
Right arrow Articles by Bender, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nesbit, G.
Right arrow Articles by Bender, C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
American Journal of Roentgenology, Vol 151, Issue 5, 933-938
Copyright © 1988 by American Roentgen Ray Society


Articles

Cholangiocarcinoma: diagnosis and evaluation of resectability by CT and sonography as procedures complementary to cholangiography

GM Nesbit, CD Johnson, EM James, RL MacCarty, DM Nagorney, and CE Bender

Department of Diagnostic Radiology, Mayo Clinic, Rochester, MN 55905.

The purpose of this study was to evaluate the usefulness of CT and sonography as procedures complementary to cholangiography in the detection and staging of cholangiocarcinoma. The studies of 42 patients with pathologically proved cholangiocarcinoma and preoperative CT (26 patients), sonography (30 patients), and cholangiography (31 patients) were reviewed blindly and retrospectively. The tumor was shown by CT in 69%, by sonography in 47%, and by cholangiography in 97% of patients. Three radiographic types of cholangiocarcinoma were identified: infiltrating stenotic (69%), bulky exophytic (19%), and polypoid intraluminal (12%). CT correctly staged 54%, sonography 50%, and cholangiography 58% of tumors as resectable (40%) or unresectable (60%). The sensitivities in detecting unresectability with CT, sonography, and cholangiography were 44%, 19%, and 43%, respectively; specificities were 78%, 100%, and 100%, respectively. CT and sonography combined with cholangiography increased the sensitivities to 64% and 50%, respectively. CT and sonography were complementary to cholangiography because they helped determine the extrabiliary extent of these tumors and therefore provided information on resectability.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
RadiologyHome page
H. J. Kim, A. Y. Kim, S. S. Hong, M.-H. Kim, J. H. Byun, H. J. Won, Y. M. Shin, P. N. Kim, H. K. Ha, and M.-G. Lee
Biliary Ductal Evaluation of Hilar Cholangiocarcinoma: Three-dimensional Direct Multi-Detector Row CT Cholangiographic Findings versus Surgical and Pathologic Results--Feasibility Study
Radiology, December 1, 2005; 238(1): 300 - 308.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
M.-S. Park, T. K. Kim, K. W. Kim, S. W. Park, J. K. Lee, J.-S. Kim, J. H. Lee, K. A. Kim, A. Y. Kim, P. N. Kim, et al.
Differentiation of Extrahepatic Bile Duct Cholangiocarcinoma from Benign Stricture: Findings at MRCP versus ERCP
Radiology, October 1, 2004; 233(1): 234 - 240.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
K. M. Vitellas, M. T. Keogan, K. S. Freed, R. A. Enns, C. E. Spritzer, J. M. Baillie, and R. C. Nelson
Radiologic Manifestations of Sclerosing Cholangitis with Emphasis on MR Cholangiopancreatography
RadioGraphics, July 1, 2000; 20(4): 959 - 975.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by the American Roentgen Ray Society.